Thymmune Therapeutics
PrivateLast Round
Grant
Sep 29, 2023
Total Funding Raised
$52M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Thymmune Therapeutics is a biotechnology company developing a proprietary T-Lymune™ platform to restore and enhance the function of the thymus to address a wide range of immune-related disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, ML Platforms
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thymmune Therapeutics Comparables
Compare Thymmune Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tolerance Bio, Inc. | 86% | |
| TECregen | 78% | |
| Stratus Therapeutics | 75% | |
Thymmune Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 29, 2023 | ||||
| Seed | Mar 1, 2023 | ||||
| Grant | Feb 1, 2023 |
Key People
Founding team and executive leadership
Thymmune Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Pags Group | Seed |
| Pillar VC | Seed |
| ARPA-H | Grant |
| NYBC Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2026
Open roles increased to 11, 39% of headcount.
- Feb 2, 2026
Monthly visitors grew 64% MoM.
Thymmune Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Thymmune Therapeutics's valuation, stock price, and market status.